News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytRx Corporation (CYTR) to Present at the GTCbio's Third Assay Development & Screening Technologies Conference


6/3/2008 8:38:14 AM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that Bin Zhang, Ph.D., Associate Director of Biochemistry and Screening, is invited to present CytRx’s novel high-content screening (HCS) assay for small molecule amplifiers of the cellular chaperone response at GTCbio’s Third Assay Development & Screening Technologies Conference being held June 5 and 6 in San Francisco. Some of the hit compounds from the HCS assay showed significant cellular protection under various stress conditions including cell-based models for both stroke and Parkinson’s disease.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES